Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-29

FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's supplemental application for clobetasol propionate, a potent topical corticosteroid, enabling an approved supplemental use or labeling u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clobetasol Propionate (generic) (clobetasol propionate)

Snippet

SUPPL AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)